<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21648">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01842412</url>
  </required_header>
  <id_info>
    <org_study_id>2013/395/REK midt</org_study_id>
    <secondary_id>2013/395/REK midt</secondary_id>
    <nct_id>NCT01842412</nct_id>
  </id_info>
  <brief_title>The Initial Effect of Training on Mitochondrial Function in Patients With Intermittent Claudication</brief_title>
  <official_title>The Initial Effect of Training on Mitochondrial Function in Patients With Intermittent Claudication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of this study is that one bout of leg exercise gives acute qualitative
      changes in mitochondrial function in claudication. Final purpose is to determine the optimal
      exercise frequency in treatment of claudication.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Mitochondrial function</measure>
    <time_frame>One day</time_frame>
    <safety_issue>No</safety_issue>
    <description>respirometry</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>claudication</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>one bout of exercise training</description>
    <arm_group_label>claudication</arm_group_label>
    <arm_group_label>healthy</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      muscle tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatient clinic, vascular surgery, Trondheim, Norway
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A history of any type of uni- or bilateral exertion leg pain.

          -  A maximal claudication distance that is less than 300 meter

          -  Diagnosed with intermittent claudication secondary to vascular insufficiency

          -  An ankle-brachial index between 0.4 and 0.9.

          -  Lives in Trondheim

        Exclusion Criteria:

          -  Diagnosed with critical limb ischemia

          -  ankle-brachial index &gt; 0.90 or &lt; 0.4

          -  Limited exercise tolerance

          -  Warfarin or heparin usage

          -  Diabetes mellitus

          -  Underwent a vascular intervention in the last 3 months

          -  Active cancer, renal- or liver disease.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ã˜yvind Ellingsen, prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegisn University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department for circulation and medical imaging, NTNU</name>
      <address>
        <city>Trondheim</city>
        <state>Postboks 8905</state>
        <zip>7491</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>April 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mitochondria, Muscle</keyword>
  <keyword>Exercise</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
